Pureland Venture

Pureland Global Venture is a direct investment fund and part of the Pureland Group which targets impact investment deals in the medical technology sector. We are Singapore-based with a focus in APAC, India and the US. The fund deals with early-stage companies who have potential to inject value into the patient care system, save lives and reduce gaps in the supply and demand chains. Since we were established, we have invested in multiple medical sectors in both medical devices and ML-based solutions.

Pureland Venture Partner Chris Hardesty champions accessibility, impact, and collaboration in healthcare

The Pureland Venture Partner and healthcare advocate shared his expert insights on the trajectory of health tech innovations, digital health, policy implications, and clinical adoption challenges, amongst other key topics.

Pureland Venture Partner Chris Hardesty champions accessibility, impact, and collaboration in healthcare

The Pureland Venture Partner and healthcare advocate shared his expert insights on the trajectory of health tech innovations, digital health, policy implications, and clinical adoption challenges, amongst other key topics.

India and Southeast Asian markets to thrive in healthtech

While China remains a front runner in healthtech, India and Southeast Asia display strong potentials in cultivating local innovation capabilities in the field.